4Q Model: How to Apply Guidelines for COPD in Primary Care

Carla Bruschelli, Germano Bettoncelli, Giorgio Carlo Monti

DOI: https://doi.org/10.7175/cmi.v12i1.1335


According to Italian General Practitioners (GPs), it is difficult to use guidelines and consensus, because they refer mainly to the disease and they are not close to the variability of real life.

To help GPs perform clinical audits and address some management problems, we have devised a new analysis methodology: four-quadrant (4Q) diagnostic analysis.

4Q model describes, in a fairly realistic way, the characteristics and clinical issues of patients with chronic obstructive pulmonary disease (COPD) during visits in the General Medicine setting. Using this model, GPs can identify and group patients in four specific areas; depending on the membership, the intervention is defined by the guidelines and the evidence-based medicine.


Management; General Practitioners; Guidelines; Four-Quadrant Model

Full Text:



  • Bettini GL, Bonvicini A, Braga A, et al. BPCO a 270°. Rivista Società Italiana di Medicina Generale 2013: 6: 11-15
  • Buist AS, McBurnie MA, Vollmer WM, et al. BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population based prevalence study. Lancet 2007; 370: 741-50; https://doi.org/10.1016/S0140-6736(07)61377-4
  • Viegi G, Pistelli F, Sherrill DL, et al. Definition, epidemiology and natural history of COPD. Eur Respir J 2007; 30: 993-1013; https://doi.org/10.1183/09031936.00082507
  • Istituto Nazionale di Statistica ISTAT. Condizioni di salute e ricorso ai servizi sanitari. Detection years 1994-2013. Edition February, 9, 2016; Available at https://www.istat.it/it/archivio/5471 (last accessed April 2018)
  • AA.VV. Broncopneumopatia cronica ostruttiva e comorbidità croniche. Italian Journal of Medicine 2011; 5 (Suppl. 1)
  • Rossi FF, Pedone C, Antonelli Incalzi R. Broncopneumopatia cronica ostruttiva e patologie cardiovascolari: ruolo dell’infiammazione sistemica. Recenti Prog Med 2011; 102: 109-13
  • World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. WHO report 2007. Available at http://www.who.int/gard/publications/GARD_Manual/en/ (last accessed March 2018)
  • Gibson GJ, Loddenkemper R, Lundbäck B, et al. Respiratory health and disease in Europe: the new European Lung White Book. Eur Respir J 2013; 42: 559-63. https://doi.org/10.1183/09031936.00105513
  • Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Eng J Med 2004; 350: 2645-53; https://doi.org/10.1056/NEJMoa032158
  • De Marco R, Accordini S, Cerveri I, et al.; European Community Respiratory Health Survey Study Group. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59: 120-5; https://doi.org/10.1136/thorax.2003.011163
  • Ministero della Salute. Piano sanitario nazionale 2011-2013; B.3 Malattie respiratorie croniche: p. 102. November, 5, 2010; Available at http://www.ipasvi.it/archivio_news/pagine/28/PIANO%20SANITARIO%20NAZIONALE.pdf (last accessed April 2018)
  • Baraldi E, Bevilacqua M, Bruschelli C, et al.; Gruppo di Lavoro GARD-Italy “Sorveglianza malattie respiratorie”. Sorveglianza nell’ambito delle patologie respiratorie. July,25, 2015. Available at http://www.salute.gov.it/imgs/C_17_pubblicazioni_2386_allegato.pdf (last accessed April 2018)
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Available at http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/ (last accessed March 2018)
  • Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease. ERS, consensus statement. Eur Respir J 1995; 8: 1398-420; https://doi.org/10.1183/09031936.95.08081398
  • National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: National Clinical Guideline Centre, 2010. Available at http://guidance.nice.org.uk/CG101/Guidance/pdf/English (last accessed March 2018)
  • AIMAR, AIPO, SIMER, et al. La gestione clinica integrata della BPCO. October, 2013. Available at https://www.simg.it/documenti/aree_cliniche/Pneumologica/supporti/gestione_bpco/Gestione%20BPCO.pdf (last accessed April 2018)
  • Bettoncelli G, Blasi F, Brusasco V, et al. The clinical and integrated management of COPD. Sarcoidosis Vasc Diffuse Lung Dis 2014; 31 Suppl 1: 3-21
  • Istituto Nazionale di Statistica (ISTAT). May, 4, 2017. Anni 2003-2014. L’evoluzione della mortalità per causa: le prime 25 cause di morte. Available at http://www.istat.it/it/files/2017/05/Report-cause-di-morte-2003-14.pdf (last accessed April 2018)
  • Luft J. Introduction à la dynamique des groups. Toulouse: Éd. Privat, 1968
  • Bettoncelli G, Monti GC, Paolini I. Analisi 4Q. Analisi diagnostica a quattro quadranti. Rivista Società Italiana di Medicina Generale 2009: 3: 42-43
  • Bruschelli C, Bettoncelli G, Monti GC. [Management of Adult Obstructive Sleep Apnea Syndrome in General Practice: a new model of risk prevention]. Clinical Management Issues 2017; 11: 31-7
  • Ministero della Salute, Istituto Superiore Sanità. Linee guida cliniche per promuovere la cessazione dell’abitudine al fumo. Aggiornamento 2008. Available at http://old.iss.it/binary/fumo/cont/linee_guida_brevi_2008.pdf (last accessed April 2018)


  • There are currently no refbacks.

© SEEd srl